A Study of CM383 in Patients With Alzheimer's Disease Related Mild Cognitive Impairment and Mild Alzheimer's Disease

Clinical trial NCT06619613 · RECRUITING

Trial details

NCT number: NCT06619613
Sponsor: Keymed Biosciences Co.Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2024-11-08
Primary completion: 2026-12-30
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.